Expanding the role of hydroxyurea in children with sickle cell disease

被引：4

作者：

Rogers, ZR ^{[1
]}

Buchanan, GR ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dallas, TX 75390 USA

来源：

JOURNAL OF PEDIATRICS | 2004年 / 145卷 / 03期

关键词：

D O I：

10.1016/j.jpeds.2004.06.032

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：287 / 288

页数：2

共 10 条

[1] Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].

Adams, RJ ;

McKie, VC ;

Hsu, L ;

Files, B ;

Vichinsky, E ;

Pegelow, C ;

Abboud, M ;

Gallagher, D ;

Kutlar, A ;

Nichols, FT ;

Bonds, DR ;

Brambilla, D ;

Woods, G ;

Olivieri, N ;

Driscoll, C ;

Miller, S ;

Wang, W ;

Hurlett, A ;

Scher, C ;

Berman, B ;

Carl, E ;

Jones, AM ;

Roach, ES ;

Wright, E ;

Zimmerman, RA ;

Waclawiw, M ;

Pearson, H ;

Powars, D ;

Younkin, D ;

El-Gammal, T ;

Seibert, J ;

Moye, L ;

Espeland, M ;

Murray, R ;

McKinley, R ;

McKinley, S ;

Hagner, S ;

Weiner, S ;

Estow, S ;

Yelle, M ;

Brock, K ;

Carter, E ;

Chiarucci, K ;

Debarr, M ;

Feron, P ;

Harris, S ;

Hoey, L ;

Jacques, K ;

Kuisel, L ;

Lewis, N .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11

[2] EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].

CHARACHE, S ;

TERRIN, ML ;

MOORE, RD ;

DOVER, GJ ;

BARTON, FB ;

ECKERT, SV ;

MCMAHON, RP ;

BONDS, DR ;

ORRINGER, E ;

JONES, S ;

STRAYHORN, D ;

ROSSE, W ;

PHILLIPS, G ;

PEACE, D ;

JOHNSONTELFAIR, A ;

MILNER, P ;

KUTLAR, A ;

TRACY, A ;

BALLAS, SK ;

ALLEN, GE ;

MOSHANG, J ;

SCOTT, B ;

STEINBERG, M ;

ANDERSON, A ;

SABAHI, V ;

PEGELOW, C ;

TEMPLE, D ;

CASE, E ;

HARRELL, R ;

CHILDERIE, S ;

EMBURY, S ;

SCHMIDT, B ;

DAVIES, D ;

KOSHY, M ;

TALISCHYZAHED, N ;

DORN, L ;

PENDARVIS, G ;

MCGEE, M ;

TELFER, M ;

DAVIS, A ;

CASTRO, O ;

FINKE, H ;

PERLIN, E ;

SITEMAN, J ;

GASCON, P ;

DIPAOLO, P ;

GARGIULO, S ;

ECKMAN, J ;

BAILEY, JH ;

PLATT, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322

[3]

Kinney TR, 1999, BLOOD, V94, P1550

[4]

OHENEFREMPONG K, 1991, SEMIN HEMATOL, V28, P213

[5] RISK OF RECURRENT STROKE IN PATIENTS WITH SICKLE-CELL DISEASE TREATED WITH ERYTHROCYTE TRANSFUSIONS [J].

PEGELOW, CH ;

ADAMS, RJ ;

MCKIE, V ;

ABBOUD, M ;

BERMAN, B ;

MILLER, ST ;

OLIVIERI, N ;

VICHINSKY, E ;

WANG, W ;

BRAMBILLA, D .

JOURNAL OF PEDIATRICS, 1995, 126 (06) :896-899

[6] Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke [J].

Scothorn, DJ ;

Price, C ;

Schwartz, D ;

Terrill, C ;

Buchanan, GR ;

Shurney, W ;

Sarniak, I ;

Fallon, R ;

Chu, JY ;

Pegelow, CH ;

Wang, W ;

Casella, JF ;

Resar, LS ;

Berman, B ;

Adamkiewicz, T ;

Hsu, LL ;

Ohene-Frempong, K ;

Smith-Whitley, K ;

Mahoney, D ;

Scott, JP ;

Woods, GM ;

Watanabe, M ;

DeBaun, MR .

JOURNAL OF PEDIATRICS, 2002, 140 (03) :348-354

[7] Hydroxyurea therapy in children severely affected with sickle cell disease [J].

Scott, JP ;

Hillery, CA ;

Brown, ER ;

Misiewicz, V ;

Labotka, RJ .

JOURNAL OF PEDIATRICS, 1996, 128 (06) :820-828

[8] Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy [J].

Ware, RE ;

Zimmerman, SA ;

Sylvestre, PB ;

Mortier, NA ;

Davis, JS ;

Treem, WR ;

Schultz, WH .

JOURNAL OF PEDIATRICS, 2004, 145 (03) :346-352

[9] Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease [J].

Ware, RE ;

Zimmerman, SA ;

Schultz, WH .

BLOOD, 1999, 94 (09) :3022-3026

[10] Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease [J].

Zimmerman, SA ;

Schultz, WH ;

Davis, JS ;

Pickens, CV ;

Mortier, NA ;

Howard, TA ;

Ware, RE .

BLOOD, 2004, 103 (06) :2039-2045

← 1 →